These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 20003093

  • 1. The clinical presentation and prognostic factors for intrahepatic and extrahepatic cholangiocarcinoma in a tertiary care centre.
    Singal AG, Rakoski MO, Salgia R, Pelletier S, Welling TH, Fontana RJ, Lok AS, Marrero JA.
    Aliment Pharmacol Ther; 2010 Mar; 31(6):625-33. PubMed ID: 20003093
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population.
    Chantajitr S, Wilasrusmee C, Lertsitichai P, Phromsopha N.
    J Hepatobiliary Pancreat Surg; 2006 Mar; 13(6):537-42. PubMed ID: 17139428
    [Abstract] [Full Text] [Related]

  • 4. CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma.
    Nishihara Y, Aishima S, Hayashi A, Iguchi T, Fujita N, Taketomi A, Honda H, Tsuneyoshi M.
    Histopathology; 2009 Oct; 55(4):423-31. PubMed ID: 19817893
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma.
    Murakami Y, Uemura K, Hayashidani Y, Sudo T, Hashimoto Y, Ohge H, Sueda T.
    J Surg Oncol; 2007 Mar 01; 95(3):207-12. PubMed ID: 17278119
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
    Ito F, Agni R, Rettammel RJ, Been MJ, Cho CS, Mahvi DM, Rikkers LF, Weber SM.
    Ann Surg; 2008 Aug 01; 248(2):273-9. PubMed ID: 18650638
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The concept of perihilar cholangiocarcinoma is valid.
    Ebata T, Kamiya J, Nishio H, Nagasaka T, Nimura Y, Nagino M.
    Br J Surg; 2009 Aug 01; 96(8):926-34. PubMed ID: 19591162
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Prognostic factors and long term outcome after surgery for hilar cholangiocarcinoma. Univariate and multivariate analysis].
    Ramacciato G, Di Benedetto F, Cautero N, Masetti M, Mercantini P, Corigliano N, Nigri G, Lauro A, Ercolani G, Del Gaudio M, De Ruvo N, Pinna AD.
    Chir Ital; 2004 Aug 01; 56(6):749-59. PubMed ID: 15771027
    [Abstract] [Full Text] [Related]

  • 13. Transcatheter arterial chemoembolization or chemoinfusion for unresectable intrahepatic cholangiocarcinoma: clinical efficacy and factors influencing outcomes.
    Kim JH, Yoon HK, Sung KB, Ko GY, Gwon DI, Shin JH, Song HY.
    Cancer; 2008 Oct 01; 113(7):1614-22. PubMed ID: 18704990
    [Abstract] [Full Text] [Related]

  • 14. Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysis.
    Vern-Gross TZ, Shivnani AT, Chen K, Lee CM, Tward JD, MacDonald OK, Crane CH, Talamonti MS, Munoz LL, Small W.
    Int J Radiat Oncol Biol Phys; 2011 Sep 01; 81(1):189-98. PubMed ID: 20971573
    [Abstract] [Full Text] [Related]

  • 15. Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy.
    Kahaleh M, Mishra R, Shami VM, Northup PG, Berg CL, Bashlor P, Jones P, Ellen K, Weiss GR, Brenin CM, Kurth BE, Rich TA, Adams RB, Yeaton P.
    Clin Gastroenterol Hepatol; 2008 Mar 01; 6(3):290-7. PubMed ID: 18255347
    [Abstract] [Full Text] [Related]

  • 16. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
    Furuse J, Okusaka T, Ohkawa S, Nagase M, Funakoshi A, Boku N, Yamao K, Yamaguchi T, Sato T.
    Cancer Chemother Pharmacol; 2009 Dec 01; 65(1):113-20. PubMed ID: 19404641
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of surgical approach for extrahepatic cholangiocarcinoma.
    Shi QF, Liang TB, Qin YS, Wang WL, Shen Y, Zhang M, Zheng SS.
    Hepatobiliary Pancreat Dis Int; 2007 Dec 01; 6(6):622-6. PubMed ID: 18086629
    [Abstract] [Full Text] [Related]

  • 18. What prognostic factors are important for resected intrahepatic cholangiocarcinoma?
    Paik KY, Jung JC, Heo JS, Choi SH, Choi DW, Kim YI.
    J Gastroenterol Hepatol; 2008 May 01; 23(5):766-70. PubMed ID: 17868336
    [Abstract] [Full Text] [Related]

  • 19. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival.
    Ohtsuka M, Ito H, Kimura F, Shimizu H, Togawa A, Yoshidome H, Miyazaki M.
    Br J Surg; 2002 Dec 01; 89(12):1525-31. PubMed ID: 12445060
    [Abstract] [Full Text] [Related]

  • 20. Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors).
    Schmitz KJ, Lang H, Kaiser G, Wohlschlaeger J, Sotiropoulos GC, Baba HA, Jasani B, Schmid KW.
    Hum Pathol; 2009 Dec 01; 40(12):1706-14. PubMed ID: 19683330
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.